BioNTech COVID-19 vaccine B.1.1.529 - Latest News & Reviews

Wednesday, August 12, 2026

BioNTech claims it will know in two weeks whether the COVID-19 vaccine it developed with Pfizer is effective against the new B.1.1.529 variant strain that is quickly spreading in southern Africa

Web & Social Media

BioNTech claims it will know in two weeks whether the COVID-19 vaccine it developed with Pfizer is effective against the new B.1.1.529 variant strain that is quickly spreading in southern Africa

Team Tech Outlook • Nov 26, 2021